David I. Finkelstein

12.5k total citations · 1 hit paper
215 papers, 9.0k citations indexed

About

David I. Finkelstein is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, David I. Finkelstein has authored 215 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Neurology, 89 papers in Cellular and Molecular Neuroscience and 55 papers in Molecular Biology. Recurrent topics in David I. Finkelstein's work include Parkinson's Disease Mechanisms and Treatments (78 papers), Alzheimer's disease research and treatments (35 papers) and Neuroscience and Neuropharmacology Research (34 papers). David I. Finkelstein is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (78 papers), Alzheimer's disease research and treatments (35 papers) and Neuroscience and Neuropharmacology Research (34 papers). David I. Finkelstein collaborates with scholars based in Australia, United States and Japan. David I. Finkelstein's co-authors include Paul A. Adlard, Ashley I. Bush, Malcolm Horne, John S. Forsythe, Scott Ayton, Dominic J. Hare, Peng Lei, David R. Nisbet, John Drago and Philip Doble and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Neuroscience.

In The Last Decade

David I. Finkelstein

211 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export

2012 472 citations Scott Ayton, David I. Finkelstein et al. profile →

Peers

Countries citing papers authored by David I. Finkelstein

Since Specialization

Citations

This map shows the geographic impact of David I. Finkelstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David I. Finkelstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David I. Finkelstein more than expected).

Fields of papers citing papers by David I. Finkelstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David I. Finkelstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David I. Finkelstein. The network helps show where David I. Finkelstein may publish in the future.

Co-authorship network of co-authors of David I. Finkelstein

This figure shows the co-authorship network connecting the top 25 collaborators of David I. Finkelstein. A scholar is included among the top collaborators of David I. Finkelstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David I. Finkelstein. David I. Finkelstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Overcoming Methodological Challenges for Advancing Stem Cell Therapies in Parkinson’s Disease 2024 ·Cell Transplantation ·Stephen Polgar, David I. Finkelstein, Leila Karimi	0
2	Levodopa Rescues Retinal Function in the Transgenic A53T Alpha-Synuclein Model of Parkinson’s Disease 2024 ·Biomedicines ·(unknown), Vickie Wong, Kirstan A. Vessey, David I. Finkelstein, Bang V. Bui, Christine T. O. Nguyen	3
3	Epsin2, a novel target for multiple system atrophy therapy via α-synuclein/FABP7 propagation 2023 ·Brain ·An Cheng, K. Kawahata, Yifei Wang, (unknown), Haoyang Wang, (unknown), Yi Chen, (unknown), Atsushi Takeda, Nadia Stefanova, David I. Finkelstein, Wenbo Ma, Min Chen, Takuya Sasaki, Kohji Fukunaga	6
4	Altered Outer Retinal Structure, Electrophysiology and Visual Perception in Parkinson’s Disease 2023 ·Journal of Parkinson s Disease ·(unknown), Pei Ying Lee, David I. Finkelstein, Allison M. McKendrick, Bao N. Nguyen, Bang V. Bui, Christine T. O. Nguyen	6
5	Clinical Sphingolipids Pathway in Parkinson’s Disease: From GCase to Integrated-Biomarker Discovery 2022 ·Cells ·(unknown), David I. Finkelstein, Nicolas H. Voelcker, David Rudd	16
6	Biomaterial Strategies for Restorative Therapies in Parkinson’s Disease 2021 ·ACS Chemical Neuroscience ·Samaneh Mirzaei, Ketav Kulkarni, Kun Zhou, Peter J. Crack, Marie‐Isabel Aguilar, David I. Finkelstein, John S. Forsythe	12
7	Distribution of Parkinson’s disease associated RAB39B in mouse brain tissue 2020 ·Molecular Brain ·Yujing Gao, Gabrielle R. Wilson, Sarah Stephenson, Mustapha Oulad‐Abdelghani, Nicolas Charlet‐Berguerand, Kiymet Bozaoglu, Catriona McLean, Paul Q. Thomas, David I. Finkelstein, Paul J. Lockhart	7
8	Misfolded α-synuclein causes hyperactive respiration without functional deficit in live neuroblastoma cells 2019 ·Disease Models & Mechanisms ·(unknown), Sarah J. Annesley, (unknown), (unknown), Matthew A. Perugini, Victoria Lawson, Paul R. Fisher, David I. Finkelstein, Andrew F. Hill	19
9	The role of lipids in alpha-synuclein misfolding and neurotoxicity 2019 ·Journal of Biological Chemistry ·(unknown), Victoria Lawson, David I. Finkelstein, Andrew F. Hill	4
10	Analogues of desferrioxamine B designed to attenuate iron-mediated neurodegeneration: synthesis, characterisation and activity in the MPTP-mouse model of Parkinson's disease 2017 ·Metallomics ·(unknown), (unknown), Paul K. Witting, Kay L. Double, David I. Finkelstein, Rachel Codd	26
11	Trehalose Improves Cognition in the Transgenic Tg2576 Mouse Model of Alzheimer’s Disease 2017 ·Journal of Alzheimer s Disease ·Stuart Portbury, Dominic J. Hare, (unknown), (unknown), (unknown), David I. Finkelstein, Paul A. Adlard	67
12	Pathogenic mechanisms of prion protein, amyloid‐β and α‐synuclein misfolding: the prion concept and neurotoxicity of protein oligomers 2016 ·Journal of Neurochemistry ·(unknown), David I. Finkelstein, Victoria Lawson, Andrew F. Hill	64
13	Is early-life iron exposure critical in neurodegeneration? 2015 ·Nature Reviews Neurology ·Dominic J. Hare, Manish Arora, Nicole L. Jenkins, David I. Finkelstein, Philip Doble, Ashley I. Bush	84
14	Role of metal ions in the cognitive decline of Down syndrome 2014 ·Frontiers in Aging Neuroscience ·(unknown), Melanie Pritchard, Paul A. Adlard, David I. Finkelstein	16
15	Intravenous Immunglobulin Binds Beta Amyloid and Modifies Its Aggregation, Neurotoxicity and Microglial Phagocytosis In Vitro 2013 ·PLoS ONE ·(unknown), Alexander Schaub, Miriam Ender, (unknown), (unknown), (unknown), Marc W. Nolte, Louis Fabri, Paul A. Adlard, David I. Finkelstein, Reinhard Bolli, Sylvia Miescher	8
16	Amine oxidase activity of β-amyloid precursor protein modulates systemic and local catecholamine levels 2012 ·Molecular Psychiatry ·James A. Duce, Scott Ayton, Alita A. Miller, Andrew Tsatsanis, Linh Q. Lam, Laura Leone, J. E. Corbin, Helmut Butzkueven, Trevor J. Kilpatrick, Jack T. Rogers, Kevin J. Barnham, David I. Finkelstein, Ashley I. Bush	12
17	Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication 2006 ·Brain Research ·(unknown), (unknown), David I. Finkelstein	78
18	Timecourse of striatal re‐innervation following lesions of dopaminergic SNpc neurons of the rat 2003 ·European Journal of Neuroscience ·Davor Stanić, David I. Finkelstein, (unknown), John Drago, M.K. Horne	121
19	Axonal sprouting following lesions of the rat substantia nigra 2000 ·Neuroscience ·David I. Finkelstein, Davor Stanić, Clare L. Parish, Doris Tomas, Kerry Dickson, M.K. Horne	163
20	The relationship between monkey ventrolateral thalamic nucleus activity and kinematic parameters of wrist movement 1996 ·Brain Research ·Ernest Butler, David I. Finkelstein, (unknown), (unknown), (unknown), Malcolm Horne	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact